Benzinga | Aug 6, 2020 04:01PM EDT

Cytokinetics Q2 EPS $(0.68) Misses $(0.57) Estimate, Sales $3.59M Miss $4.07M Estimate

Cytokinetics (NASDAQ:CYTK) reported quarterly losses of $(0.68) per share which missed the analyst consensus estimate of $(0.57) by 19.3 percent. This is a 21.43 percent decrease over losses of $(0.56) per share from the same period last year. The company reported quarterly sales of $3.59 million which missed the analyst consensus estimate of $4.07 million by 11.79 percent. This is a 49.70 percent decrease over sales of $7.14 million the same period last year.